From the Division of Pharmaceutical Evaluation and Policy (Dr Martin), University of Arkansas for Medical Sciences, Little Rock, Ark; Pennington Biomedical Research Center (Dr Church), Baton Rouge, La; Human Centric Software (Mr Bonnell), Minneapolis, Minn; Health Outcomes (Dr Ben-Joseph), Sanofi-Aventis, Bridgewater, NJ; and Trestle Tree (Mr Borgstadt), Springdale, Ark.
Address correspondence to: Bradley C. Martin, PharmD, PhD, Division of Pharmaceutical Evaluation and Policy, University of Arkansas for Medical Sciences, 4301 W. Markham Street, Slot 522, Little Rock, AR 72205; E-mail:[email protected].